We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Agilent Technologies Flx Mab Ahu Ck19 Cl Rck108, Rtu (Omnis)
List Price
$945.00
Your Price
$945.00
Agilent Technologies Flx Mab Ahu Ck19 Cl Rck108, Rtu (Omnis) - AGIMSD (Additional S&H or Hazmat Fees May Apply)
NETA PART:
PTMSD-GA61561-2
MFG.PART:
GA61561-2
UNSPSC:
12352203
Manufacturer:
Agilent Technologies
Agilent Technologies Flex Monoclonal Mouse Anti-Human Cytokeratin 19, Clone Rck108, Ready-To-Use (Dako Omnis), Unconjugated, Packaged In Vials For Use With Dako Omnis, Immunohistochemistry, 60 Tests, 12 mL. Specifications:- Antibody Solution: Dako Omnis. Clone: Rck108. Code No: Ga615. Ean/Upc Code: 05700572033370. Form/Configuration: Ready-To-Use, Flex. Immunogen: Cytoskeletal Preparation From Human Bladder Cancer Cell Line T24 (1). See Package Insert For Reference(S). Isotype: Igg1, Kappa. Jan Code: 4987582501766. Pathology Application: Formalin;Hier. Reagent Provided: Ready-To-Use Monoclonal Mouse Antibody Provided In Liquid Form In A Buffer Containing Stabilizing Protein And 0.015 Mol/L Sodium Azide. Species: Mouse Anti-Human. Specificity (Detailed): In Western Blotting Of Cytoskeleton Preparations From The T24 And Rt4 Cell Lines As Well As The Human Squamous Carcinoma Cell Line Hacat, The Antibody Labels A Single Band Corresponding To Ck19 (1). In Immunohistochemistry On Different Human Tissues, The Antibody Labels Only Epithelia, Whereas Cells Known Not To Contain Ck19, E.g. Hepatocytes, Are Not Labeled (1). See Package Insert For Reference(S). - AGIMSD (Additional S&H or Hazmat Fees May Apply)
| SKU | PTMSD-GA61561-2 |
|---|---|
| Supplier Part Number | GA61561-2 |
| UM | EA |
| UNSPSC | 12352203 |
| Manufacturer | Agilent Technologies |
| CountryOfOrigin | Origin Varies |
| ProductLine | AGIMSD |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |